Cohen, J. B., Switchenko, J. M., Koff, J. L., Sinha, R., Kaufman, J. L., Khoury, H. J., . . . Flowers, C. R. (2015). A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent non-Hodgkin’s Lymphoma. Br J Haematol.
Styl ChicagoCohen, Jonathon B., et al. "A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin’s Lymphoma." Br J Haematol 2015.
Citace podle MLACohen, Jonathon B., et al. "A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin’s Lymphoma." Br J Haematol 2015.